BUZZ-Immuneering jumps after positive initial data on cancer therapy
Reuters · 6d ago
BUZZ-Immuneering jumps after positive initial data on cancer therapy
** Shares of cancer drug developer Immuneering Corp IMRX.O jump ~72% to $2.50
** Co says its pancreatic cancer therapy, IMM-1-104, reduced or eliminated tumors in 40% of the five patients tested in a mid-stage study
** Co expects to report data from at least another group of patients in the mid-stage study by year-end
** Despite session gains, stock still down ~67% YTD
(Reporting by Kashish Tandon)
((Kashish.tandon@thomsonreuters.com))
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.